Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns (Nature (2016) 538 (378-382) DOI: 10.1038/nature19823);A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns

Nature

Volumn 538, Issue 7625, 2016, Pages 378-382

  Notta, Faiyaz ^a   Chan Seng Yue, Michelle ^a   Lemire, Mathieu ^a   Li, Yilong ^b   Wilson, Gavin W ^a   Connor, Ashton A ^a   Denroche, Robert E ^a   Liang, Sheng Ben ^c   Brown, Andrew M K ^a   Kim, Jaeseung C ^a,d   Wang, Tao ^d   Simpson, Jared T ^a,e   Beck, Timothy ^a   Borgida, Ayelet ^f   Buchner, Nicholas ^a   Chadwick, Dianne ^c   Hafezi Bakhtiari, Sara ^a,c   Dick, John E ^a,d,g   Heisler, Lawrence ^a   Hollingsworth, Michael A ^f   Ibrahimov, Emin ^a   Jang, Gun Ho ^a   Johns, Jeremy ^a   Jorgensen, Lars G T ^a   Law, Calvin ^h   Ludkovski, Olga ^g   Lungu, Ilinca ^a   Ng, Karen ^a   Pasternack, Danielle ^a   Petersen, Gloria M ⁱ   Shlush, Liran I ^g   Timms, Lee ^a   Tsao, Ming Sound ^d,g   Wilson, Julie M ^a   Yung, Christina K ^a   Zogopoulos, George ^j   Bartlett, John M S ^a   Alexandrov, Ludmil B ^k   Real, Francisco X ^l   Cleary, Sean P ^c,m   Roehrl, Michael H ^c,g   McPherson, John D ^a,d   Stein, Lincoln D ^a,d   Hudson, Thomas J ^a,d   Campbell, Peter J ^b,n   Gallinger, Steven ^a,c,m   more..

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f NEBRASKA MEDICAL CENTER   (United States)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

ⁱ MAYO CLINIC   (United States)

^j RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^k CENTER FOR NONLINEAR STUDIES   (United States)

^l Structural Biology and Biocomputing Programme   (Spain)

^m MOUNT SINAI HOSPITAL   (Canada)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CANCER; DIVERGENCE; EVOLUTIONARY BIOLOGY; GENETIC ANALYSIS; GENOMICS; LESION; MUTATION; PUNCTUATED EQUILIBRIUM;

ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; DISEASE COURSE; FEMALE; GENE DOSAGE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOSIS; PANCREAS CANCER; POLYPLOIDY; PRIORITY JOURNAL; TUMOR GENE; TUMOR INVASION; BIOLOGICAL MODEL; CARCINOMA IN SITU; CHROMOTHRIPSIS; COPY NUMBER VARIATION; GENETICS; HUMAN GENOME; METASTASIS; MOLECULAR EVOLUTION; MUTAGENESIS; MUTATION; PANCREAS TUMOR; PATHOLOGY; PRECANCER;

CARCINOGENESIS; CARCINOMA IN SITU; CHROMOTHRIPSIS; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; EVOLUTION, MOLECULAR; FEMALE; GENE REARRANGEMENT; GENES, NEOPLASM; GENOME, HUMAN; HUMANS; MALE; MITOSIS; MODELS, BIOLOGICAL; MUTAGENESIS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; POLYPLOIDY; PRECANCEROUS CONDITIONS;

EID: 84992386135     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature20164     Document Type: Erratum

References (30)

1. Hruban, R. H., Goggins, M., Parsons, J., Kern, S. E. Progression model for pancreatic cancer. Cancer Res. 6, 2969-2972 (2000).
2. Moskaluk, C. A., Hruban, R. H., Kern, S. E. p16 and K-RAS gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 57, 2140-2143 (1997).
3. Wilentz, R. E. et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 58, 4740-4744 (1998).
4. Wilentz, R. E. et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60, 2002-2006 (2000).
5. Lüttges, J. et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am. J. Pathol. 158, 1677-1683 (2001).
6. Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880-886 (2015).
7. Cooper, C. S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367-372 (2015).
8. Ross-Innes, C. S. et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat. Genet. 47, 1038-1046 (2015).
9. Stachler, M. D. et al. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat. Genet. 47, 1047-1055 (2015).
10. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
11. Chari, S. T. et al. Early detection of sporadic pancreatic cancer: summative review. Pancreas 44, 693-712 (2015).
12. Eldredge, N., Gould, S. J. in Models in Paleobiology (ed. Schopf, T. J. M. ) 82-115 (Freeman, Cooper and Company, 1972).
13. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495-501 (2015).
14. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010).
15. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
16. Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140 (2013).
17. Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59-71 (2012).
18. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
19. Real, F. X. A. A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology 124, 1958-1964 (2003).
20. Zhang, C.-Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179-184 (2015).
21. Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J., de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641-1654 (2015).
22. Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209-216 (2015).
23. Li, Y. et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 508, 98-102 (2014).
24. Murphy, S. J. et al. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology 145, 1098-1109. e1 (2013).
25. Özdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719-734 (2014).
26. Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747 (2014).
27. Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483 (2005).
28. Haeno, H. et al. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148, 362-375 (2012).
29. Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361 (2012).
30. Korbel, J. O., Campbell, P. J. Criteria for inference of chromothripsis in cancer genomes. Cell 152, 1226-1236 (2013).